Related Experiment Video
Updated: Feb 4, 2026

10:31
Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
13.4K
Microcystic stromal tumor resected by laparoscopic surgery
Midori Murakami1,2, Junko Wroblewski2,3, Hidehiro Kawagoe2
1Department of Obstetrics and Gynecology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Japan.
Gynecology and Minimally Invasive Therapy
|September 27, 2018
Summary
This study presents a laparoscopic resection of a rare ovarian microcystic stromal tumor (MCST). The case highlights the management of unexpected ovarian masses during surgery.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Laparoscopic Surgery
Background:
- Microcystic stromal tumor (MCST) is an exceptionally rare ovarian neoplasm characterized by specific microcystic architectural patterns and stromal tumor immunophenotype.
- Ovarian tumors often require surgical intervention, with laparoscopy being a common minimally invasive approach.
Observation:
- A 26-year-old woman presented with a suspected left ovarian endometrial cyst, measuring 8 cm and containing hemorrhagic fluid.
- Laparoscopic surgery was performed, and initial attempts at cystectomy were converted to a left salpingo-oophorectomy due to intraoperative findings.
Findings:
- Postoperative pathological examination confirmed the diagnosis of microcystic stromal tumor (MCST).
- While MCST is not currently classified as malignant, its association with beta-catenin gene mutations warrants further investigation into its long-term behavior and prognosis.
Implications:
- This case demonstrates the successful laparoscopic management of an incidentally discovered ovarian MCST, a procedure not extensively documented.
- It underscores the importance of intraoperative assessment and adaptability in managing unexpected ovarian pathologies during minimally invasive surgery.
- Further research is needed to understand the long-term implications and potential malignant associations of ovarian MCST.
Related Concept Videos
Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Loss of Tumor Suppressor Gene Functions
6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K

